This inventor holds 1 USPTO granted patent. Top assignee: Bayer Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Innovations in Nasal Drug Delivery by Neville M Concessio
Introduction
Neville M Concessio is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of nasal drug delivery systems. His innovative work focuses on improving the efficacy and safety of drug administration through the nasal route.
Latest Patents
Concessio holds a patent for "Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations." This invention relates to pharmaceutical compositions designed for the delivery of drugs intended to reside in the nose. It specifically addresses antiviral agents that utilize the human major rhinovirus receptor, also known as intercellular adhesion molecule-1 (ICAM-1). The patent also outlines methods for creating these nasal drug compositions and an improved process for removing residual solvents from pharmaceutical matrices.
Career Highlights
Neville M Concessio is currently associated with Bayer Corporation, where he continues to advance his research in pharmaceutical formulations. His work has the potential to enhance the treatment of viral infections through more effective drug delivery systems.
Collaborations
Concessio collaborates with notable colleagues, including Kris P Antonsen and Michael A Shearer, who contribute to his research endeavors and help drive innovation in the field.
Conclusion
Neville M Concessio's contributions to nasal drug delivery represent a significant advancement in pharmaceutical technology. His innovative approaches are paving the way for more effective treatments in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
